| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 08/18/1994 | CA2155337A1 Method for inactivating viruses devoid of lipid envelopes |
| 08/18/1994 | CA2155109A1 Use of a pharmaceutical composition comprising an effective amount of interleukin-10, an analog and/or an agonist of interleukin-10 |
| 08/18/1994 | CA2155103A1 Tnf-alpha muteins and a process for preparing them |
| 08/18/1994 | CA2154266A1 Human carcinoma antigen (hca), hca antibodies, hca immunoassays, methods of imaging and therapy |
| 08/18/1994 | CA2153162A1 New polypeptides having serotoninergic receptor activity, nucleic acids coding therefor and uses thereof |
| 08/18/1994 | CA2115807A1 Purified form of streptogramins, its preparation and pharmaceutical compositions containing same |
| 08/17/1994 | EP0611228A2 Technique for extracorporeal treatment of blood |
| 08/17/1994 | EP0611157A2 Method to prepare nucleic acids from a biological sample using low pH and acid protease |
| 08/17/1994 | EP0610842A2 Beta-Tubulin from Acremonium chrysogenum, preparation and use |
| 08/17/1994 | EP0610729A1 Procedure for the purification of proteins and peptides from lipid-containing solutions |
| 08/17/1994 | EP0610499A1 Proteoglycan(g 009) effective in enhancing antitumor immunity |
| 08/17/1994 | EP0610481A1 Extraction of collagen |
| 08/17/1994 | EP0610475A1 Enzymatically-produced dimeric il-2 and a nerve-derived transglutaminase enzyme for its preparation |
| 08/17/1994 | EP0610446A1 Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid |
| 08/17/1994 | EP0610445A1 Compositions comprising a bactericidal/permeability increasing protein and a lipid carrier, methods of making same, and uses thereof |
| 08/17/1994 | EP0610436A1 Hepatitis-c virus testing |
| 08/17/1994 | EP0610432A1 C8-cyclic peptidomimetics as fibrinogen antagonists |
| 08/17/1994 | EP0610431A1 Hiv protease inhibitors containing guanidine |
| 08/17/1994 | EP0610427A1 TGF-$g(b) TYPE RECEPTOR cDNAS AND USES THEREFOR |
| 08/17/1994 | EP0610420A1 Cell cycle controlling compositions and methods of using same |
| 08/17/1994 | EP0610356A1 Diagnosis and treatment of bacterial dysentery |
| 08/17/1994 | EP0610336A1 Treatment of neurological conditions by an interleukin-1 inhibiting compound |
| 08/17/1994 | EP0610335A1 Recombitope peptides |
| 08/17/1994 | EP0610330A1 Monoclonal antibodies directed against the microtubule-associated protein tau. |
| 08/17/1994 | EP0610322A1 Helicobacter pylori genes necessary for the regulation and maturation of urease, and use thereof |
| 08/17/1994 | EP0610320A1 Purified chitin deacetylase |
| 08/17/1994 | EP0610317A1 Inhibitors of dipeptidyl-aminopeptidase type iv |
| 08/17/1994 | EP0610298A1 Preventing allograft rejection with antibodies to adhesion molecules |
| 08/17/1994 | EP0610286A1 Recombinant immunotoxins |
| 08/17/1994 | EP0610260A1 Vaccines for actinobacillus pleuropneumoniae |
| 08/17/1994 | EP0610254A1 Glial derived neurotrophic factor |
| 08/17/1994 | EP0610246A1 Novel thrombin-inhibiting protein from ticks |
| 08/17/1994 | EP0610245A1 Colostrum fraction and its use thereof as cell culture media supplement |
| 08/17/1994 | EP0610201A1 Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 08/17/1994 | EP0595993A4 Isolation of charged particles from fluids |
| 08/17/1994 | EP0504361A4 Megakaryocyte and platelet growth, production and composition |
| 08/17/1994 | EP0434727A4 Red-shifted phthalocyanine and tetrabenztriazaporphyrin reagents |
| 08/17/1994 | EP0305387B1 Insulinotropic hormone |
| 08/17/1994 | EP0265500B1 Antibody to human progesterone receptor and diagnostic materials and methods |
| 08/17/1994 | CN1090928A Method for early detection, detection of the severity and for a treatment-accompanying assessment of the course of a sepsis, as well as a means for carrying out said method |
| 08/16/1994 | US5338858 Viricides |
| 08/16/1994 | US5338850 Pyridinium derivatives |
| 08/16/1994 | US5338842 Yersinia INV nucleic acids |
| 08/16/1994 | US5338840 DNA encoding glioma-derived growth factor having vascular endothelial cell growth promoting activity |
| 08/16/1994 | US5338839 Diagnosis of brain tumors |
| 08/16/1994 | US5338836 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 08/16/1994 | US5338835 Mutant forms with unique glycosylation patterns |
| 08/16/1994 | US5338834 Ultrapure human interleukin-6 |
| 08/16/1994 | US5338833 Carboxy terminal IL-6 muteins |
| 08/16/1994 | US5338830 Cyclic peptides having diuretic and vasodilation activity |
| 08/16/1994 | US5338829 Peptides derived from human immunodeficiency virus-1 GP160 |
| 08/16/1994 | US5338725 Anti-aggregatory agents for platelets |
| 08/16/1994 | US5338724 Antimicrobial proteins, compositions containing same and uses thereof |
| 08/16/1994 | US5338723 Anticoagulants and thrombus preventatives comprising cyclic hexapeptides having a synthetic amino acid replace arginine in the sequence of arginine/glycine/aspartic acid |
| 08/16/1994 | US5338683 Genetic engineering, vaccines |
| 08/16/1994 | US5338682 Starters for fermented foods which also suppress acid formation in milk during storage or transportation |
| 08/16/1994 | US5338675 Toxic metabolic product of Hirsutella sp. |
| 08/16/1994 | US5338670 Using culture medium containing controlled amounts of ferrous sulfate, dissolved oxygen and antifoam agent |
| 08/16/1994 | US5338668 Opioid peptides derived from wheat proteins |
| 08/16/1994 | US5338663 Interferes with formation of specific complex between alpha-antichymotrypsin and beta-protein; hydrolysis of substrate does not occur |
| 08/16/1994 | US5338661 Monoclonal antibody specific for a human tumour-associated antigen |
| 08/16/1994 | US5338547 Providing soybean solubles produced from acidic aqueous-extracted hexane-defatted soybenas, diluting with aqueous solution to slurry, separating, diluting again, performing ultrafiltration, drying, administering |
| 08/16/1994 | US5338544 Genetically engineered from Bacillus thuringiensis |
| 08/16/1994 | US5338543 Thimerosal inactivated mycoplasma hyopneumoniae vaccine |
| 08/16/1994 | CA2115532A1 Pseudopeptides having an antiviral action |
| 08/16/1994 | CA1331499C Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments |
| 08/16/1994 | CA1331497C Guanidic compounds comprising a tetraphenylborate ion, process to prepare such compounds and their use for the synthesis of peptides |
| 08/16/1994 | CA1331445C Vaccine against e. coli septicaemia in poultry |
| 08/13/1994 | CA2115522A1 Hst-2 mutein, dna coding for the same and preparation thereof |
| 08/13/1994 | CA2115507A1 .beta.-tubulin from acremonium chrysogenum, its preparation and use |
| 08/11/1994 | DE4404124A1 Mutierte Tumor-Nekrose-Faktor-Proteine Mutant tumor necrosis factor-proteins |
| 08/11/1994 | DE4310516A1 Lipoprotein (a) peptides and their use |
| 08/11/1994 | DE4303744A1 Canine growth hormone |
| 08/10/1994 | EP0610078A1 Cytotoxic and antiviral compound |
| 08/10/1994 | EP0610046A2 Expression vectors encoding bispecific fusion proteins and methods of producing biologically active bispesific fusion proteins in a mammalian cell |
| 08/10/1994 | EP0609901A1 T-cell receptor-specific for antigen polypeptides and related polynucleotides |
| 08/10/1994 | EP0609894A2 Labeled complex and method of analysis therewith |
| 08/10/1994 | EP0609885A1 Acridinium compounds and conjugates thereof |
| 08/10/1994 | EP0609722A1 An in vitro method for detecting the presence of invasive stimuli in mammals |
| 08/10/1994 | EP0609580A1 Recombinant CMV neutralising proteins |
| 08/10/1994 | EP0609393A1 VIRULENCE ASSOCIATED PROTEINS IN $i(BORRELIA BURGDORFERI (Bb)) |
| 08/10/1994 | EP0609359A1 Dimorphism genes in fungi |
| 08/10/1994 | EP0609293A1 Treatment of haemophilia |
| 08/10/1994 | EP0609292A1 Soluble variants of type i membrane proteins, and methods of using them |
| 08/10/1994 | EP0609280A1 Human il-3 variants |
| 08/10/1994 | EP0609242A1 New thrombin-inhibiting protein isolated from ticks. |
| 08/10/1994 | EP0609240A1 Receptor of the thyroid/steroid hormone receptor superfamily |
| 08/10/1994 | EP0564561A4 Peptides ketoamides, ketoacids, and ketoesters |
| 08/10/1994 | EP0181929B1 Trans-acting transcriptional factors |
| 08/10/1994 | CN1090584A Synthetic polypeptides |
| 08/10/1994 | CN1090510A Interferon tau compositions and methods of use |
| 08/10/1994 | CN1090509A Pharmaceutical composition |
| 08/09/1994 | US5336782 Long chain carboxylic acid imide ester |
| 08/09/1994 | US5336760 Method and useful apparatus for preparing pharmaceutical compositions |
| 08/09/1994 | US5336759 Biologically active peptide derived from frog (frog CNP) |
| 08/09/1994 | US5336758 AIDS vaccines |
| 08/09/1994 | US5336756 Dissolving in propanol allowing to crystallize |
| 08/09/1994 | US5336667 Polypeptides from snake venom inhibiting binding of von Willebrand factor |
| 08/09/1994 | US5336666 Immunostimulant drug based on polar glyopeptidolipids of mycobacterium chelonae |
| 08/09/1994 | US5336618 Monoclonal antibody of the class IgG1, designated 7E3, reacts readily with both normal human and dog blood platelets while fail to react with thrombasthenic human platelets |